Article

Wills ophthalmologists see alarming increase in rate of Acanthamoeba keratitis

Ophthalmologists at Wills Eye Hospital, Philadelphia, have seen a recent dramatic increase in cases of Acanthamoeba keratitis.

Chicago-Ophthalmologists at Wills Eye Hospital, Philadelphia, have seen a recent dramatic increase in cases of Acanthamoeba keratitis.

Speaking at the annual meeting of the American Academy of Ophthalmology, Fabiano N. Rocha, MD, reported this infection was seen in 19 patients between January 2004 and August 2005.

All 19 patients had a history of frequent replacement contact lens wear and were using multipurpose solutions for lens care. In 42% of patients there was a history of exposure to well water, while 26% reported swimming without removing their lenses.

At the time of presentation to Wills Eye Hospital, nearly three-fourths of the patients had been misdiagnosed with herpex simplex virus keratitis and had received steroids.

Upon diagnosis of Acanthamoeba keratitis, all of the patients received combined therapy with topical antiamoebic drugs. Among 9 patients who completed their antiamoebic therapy, best corrected visual acuity was 20/30 or better in seven and count fingers to hand motion in the other two. Overall, visual outcomes were better in patients who presented with epithelial radial keratitis compared with those who had a ring ulcer or stromal disease at the time of presentation.

“We are concerned about this recent increase in cases of Acanthamoeba keratitis in patients using frequent replacement contact lenses and multipurpose solutions and believe our experience underlines the importance of maintaining a high index of suspicion for this infection since early diagnosis is important to improve prognosis,” said Dr. Rocha.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.